Sensei Biotherapeutics, Inc.
NASDAQ:SNSE
0.4055 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||||||||
| Net Income
| -7.77 | -7.253 | -7.142 | -7.992 | -7.414 | -7.124 | -9.386 | -10.177 | -12.232 | -13.416 | -10.535 | -12.405 | -9.366 | -9.685 | -9.771 | -7.972 | -5.131 | -5.367 | -4.91 | -4.692 | -6.705 |
| Depreciation & Amortization
| 0.331 | 0.332 | 0 | 0.137 | 0.135 | 0.332 | 0.332 | 0.358 | 0.351 | 0.342 | 0.32 | 0.334 | 0.329 | 0.136 | 0.122 | 0.098 | 0.07 | 0.064 | 0.052 | 0.023 | 0.023 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0.356 | -0.214 | -0.142 | 0 | 0 | 0 | 0 | 0 | 0.199 | -0.353 | 0.173 | 0 | 0 | 0 | 0 | -1.04 | 1.827 |
| Stock Based Compensation
| 0.391 | 0.733 | 0.795 | 1.216 | 1.098 | 1.048 | 1.095 | 1.213 | 1.399 | 1.479 | 1.419 | 1.515 | 0.826 | 1.736 | 1.746 | 1.349 | 0.354 | 0.781 | 0.163 | 0.194 | 0.391 |
| Change In Working Capital
| 0.25 | 1.342 | 0.085 | -1.427 | -0.4 | 0.979 | -1.715 | -3.194 | 0.655 | 4.545 | -3.525 | -0.667 | 0.093 | 2.588 | 1.681 | -4.245 | 2.023 | -1.278 | 1.384 | -2.526 | 1.621 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| 0 | -0.324 | 0 | 0.306 | -0.781 | 0.471 | -2.263 | 0.242 | 2.017 | 2.234 | -2.677 | 2.644 | -1.018 | 0.74 | 0.732 | -1.88 | 2.812 | -2.524 | 1.151 | -1.104 | 1.624 |
| Other Working Capital
| 0.25 | 1.666 | 0.085 | -1.733 | 0.381 | 0.508 | 0.548 | -3.436 | -1.362 | 2.311 | -0.848 | -3.311 | 1.111 | 1.848 | 0.949 | -2.365 | -0.789 | 1.246 | 0.233 | -1.422 | -0.003 |
| Other Non Cash Items
| 1.006 | -0.624 | 0.47 | 1.634 | 0.062 | 0.318 | 0.353 | 0.064 | 0.253 | 0.247 | 0.422 | 0.473 | 0.051 | 0.001 | 0.002 | 0.003 | 0.004 | 0.002 | 0.544 | 1.581 | 1.192 |
| Operating Cash Flow
| -5.792 | -5.47 | -5.792 | -7.616 | -6.163 | -4.661 | -9.463 | -11.736 | -9.574 | -6.803 | -11.899 | -10.75 | -7.868 | -5.577 | -6.047 | -10.767 | -2.68 | -5.798 | -2.767 | -6.46 | -1.651 |
| Investing Activities: | |||||||||||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | -0.109 | -0.037 | 0 | 0 | -0.029 | -0.151 | -0.071 | -0.25 | -0.052 | -0.019 | -0.535 | -0.388 | -0.616 | -0.487 | -0.316 | -0.836 | -0.002 | -0.052 | -0.044 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | -0.166 | 0 | 0.157 | 0 | 0 | 0.015 | -0.013 | 0 | -120.886 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Purchases Of Investments
| -17.766 | -8.836 | -11.734 | -6.259 | -2.613 | -8.688 | -0.002 | -9.846 | 18.148 | -21.748 | -35.252 | -8.017 | -9.853 | -26.671 | -147.145 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 14.615 | 21.75 | 18.75 | 12.066 | 10.875 | 17 | 19.4 | 12.3 | -2.105 | 30.5 | 48.5 | 20.229 | 16 | 26.259 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0.006 | 0.166 | 0.008 | 0.02 | 0.009 | 0.071 | 0.009 | 0.013 | 0.012 | 120.886 | 26.577 | -147.145 | 0 | 0 | 0 | -0.197 | 0 | 0 |
| Investing Cash Flow
| -3.151 | 12.914 | 6.907 | 5.77 | 8.262 | 8.312 | 19.526 | 2.312 | 16.043 | 8.517 | 13.196 | 12.193 | 5.612 | -0.482 | -147.761 | -0.487 | -0.316 | -0.836 | -0.199 | -0.052 | -0.044 |
| Financing Activities: | |||||||||||||||||||||
| Debt Repayment
| -0.207 | -0.204 | -0.201 | -0.199 | -0.196 | -0.19 | -0.189 | -0.186 | -0.177 | -0.163 | -0.156 | -0.133 | -0.227 | -0.007 | -0.011 | -0.01 | -0.01 | -0.01 | 0.556 | -0.01 | 1.492 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.238 | 0 | 0 | 0.238 | 0.029 | 0 | 23.491 | 140.594 | 0.541 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | -0 | -0.252 | -2.344 | -7.788 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.013 | 0 | 0.021 | -0.01 | 0.017 | 0 | 0.031 | -0.076 | 0.053 | 0 | 0.037 | 0.252 | 0.109 | 0 | 0 | 23.492 | 15.869 | 8.491 | 0 | 10.567 | 0.154 |
| Financing Cash Flow
| -0.194 | -0.204 | -0.18 | -0.209 | -0.431 | -2.534 | -7.946 | -0.262 | -0.124 | -0.163 | -0.119 | 0.119 | -0 | -0 | -0 | 0.164 | 15.859 | 8.481 | 0.556 | 10.557 | 1.646 |
| Other Information: | |||||||||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 11.503 | 0 | -11.503 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -9.137 | 7.24 | 0.935 | -2.055 | 1.668 | 1.117 | 2.117 | -9.686 | 6.345 | 1.551 | 1.178 | 1.562 | -2.374 | -6.066 | -153.819 | 152.822 | 12.863 | 1.847 | -2.41 | 4.045 | -0.049 |
| Cash At End Of Period
| 9.994 | 19.131 | 11.891 | 10.956 | 13.011 | 11.343 | 10.226 | 8.109 | 17.795 | 11.45 | 9.899 | 8.721 | 7.159 | 9.533 | 15.599 | 169.418 | 16.596 | 3.733 | 1.886 | 4.296 | 0.251 |